CD133 Antibodies

Santa Cruz Biotechnology offers a broad range of CD133 monoclonal antibodies for advanced research in stem cell biology and cancer studies. CD133 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD133, also known as prominin-1, is a glycoprotein that plays a critical role in the maintenance of stem cell properties and the regulation of cell signaling pathways. CD133 expression is often associated with cancer stem cells, making it a significant marker in cancer research and therapeutic targeting. Understanding CD133 function is essential for developing strategies to combat tumor growth and metastasis. CD133 research has revealed important insights into cellular development and cancer progression. Ongoing studies continue to uncover new aspects of CD133's role in stem cell maintenance and cancer development. Research utilizing CD133 monoclonal antibodies has enhanced understanding of cancer stem cell biology and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for CD133 support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.